Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol describes the production of a mouse extrahepatic bile duct 3-dimensional organoid system. These biliary organoids can be maintained in culture to study cholangiocyte biology. Biliary organoids express markers of both progenitor and biliary cells and are composed of polarized epithelial cells.

Abstract

Cholangiopathies, which affect extrahepatic bile ducts (EHBDs), include biliary atresia, primary sclerosing cholangitis, and cholangiocarcinoma. They have no effective therapeutic options. Tools to study EHBD are very limited. Our purpose was to develop an organ-specific, versatile, adult stem cell-derived, preclinical cholangiocyte model that can be easily generated from wild type and genetically engineered mice. Thus, we report on the novel technique of developing an EHBD organoid (EHBDO) culture system from adult mouse EHBDs. The model is cost-efficient, able to be readily analyzed, and has multiple downstream applications. Specifically, we describe the methodology of mouse EHBD isolation and single cell dissociation, organoid culture initiation, propagation, and long-term maintenance and storage. This manuscript also describes EHBDO processing for immunohistochemistry, fluorescent microscopy, and mRNA abundance quantitation by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). This protocol has significant advantages in addition to producing EHBD-specific organoids. The use of a conditioned medium from L-WRN cells significantly reduces the cost of this model. The use of mouse EHBDs provides almost unlimited tissue for culture generation, unlike human tissue. Generated mouse EHBDOs contain a pure population of epithelial cells with markers of endodermal progenitor and differentiated biliary cells. Cultured organoids maintain homogenous morphology through multiple passages and can be recovered after a long-term storage period in liquid nitrogen. The model allows for the study of biliary progenitor cell proliferation, can be manipulated pharmacologically, and may be generated from genetically engineered mice. Future studies are needed to optimize culture conditions in order to increase plating efficiency, evaluate functional cell maturity, and direct cell differentiation. Development of co-culture models and a more biologically neutral extracellular matrix are also desirable.

Introduction

Cholangiopathies are incurable chronic progressive disorders that affect biliary cells located in intra- and extrahepatic biliary ducts (EHBDs)1. Some cholangiopathies, like primary sclerosing cholangitis, cholangiocarcinoma, biliary atresia, and choledochal cysts, predominantly affect EHBDs. Development of therapies for cholangiopathies is restricted by the limited availability of preclinical models. In addition, previous studies focused on cholangiopathies grouped together: liver, intra-, and EHBDs. However, intra- and EHBDs have a distinct embryonic origin and, thus, should be considered as distinct molecular pathologies. Intrahepatic bile d....

Protocol

All methods described here have been approved by the Institutional Animal Care and Use Committee (IACUC) of The University of Michigan.

1. Preparation of Equipment and Materials for Mouse EHBD Isolation

  1. Prepare seeding medium and washing buffer (Table of Materials) in 50 mL conical tubes and keep them at 4 °C or on ice until use.
  2. Set up a surgical table (Figure 1B). Prepare sterilized surgical instruments (

Representative Results

Our protocol describes the generation of mouse EHBD organoids that are tissue-specific and adult stem cell-derived. After the organoids are cultured, a cystic structure formation can be observed as early as 1 day after the EHBD isolation. Contamination with fibroblasts is not typically observed during culture generation. EHBDO plating efficiency is approximately 2% when isolated from either neonatal or adult (older than 2 months) mice (Figure 2B). Plating eff.......

Discussion

This work describes the generation of an organotypic 3-dimensional model of mouse EHBD cholangiocytes. Important steps in EHBDO culture generation include meticulous EHBD dissection to avoid pancreas cell contamination, maintenance of sterile conditions to prevent bacterial and fungal contamination, and careful manipulation after centrifugation to avoid the loss of cellular material. A close adherence to described temperature conditions is required. There are some limitations to the technique. EHBDs of adult mice are sma.......

Acknowledgements

This work was supported by the American Association for the Study of Liver Diseases Pinnacle award (to N.R.) and the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (awards P30 DK34933 to N.R., P01 DK062041 to J.L.M.). We thank Dr. Ramon Ocadiz-Ruiz (University of Michigan) for his assistance with development of this methodology.

....

Materials

NameCompanyCatalog NumberComments
L-WRN cell culture medium
Advanced DMEM/F12Life Technologies12634-010
Fetal Bovine Serum (FBS)1%Life Technologies10437-028
Penicillin-Streptomycin100 U/mLLife Technologies15140-122
Washing buffer
Phosphate Buffered Saline (PBS)50 mLLife Technologies10010-023
Penicillin-Streptomycin125 U/mLLife Technologies15140-122
Amphotericin B 6.25 µg/mLLife Technologies15290-018
Organoid culture medium
L-WRN Conditioned medium 1:1ATCCCRL-3276
Advanced DMEM/F121:1Life Technologies12634-010
Penicillin-Streptomycin100 U/mLLife Technologies15140-122
N-Glutamine10 µl/mLLife Technologies35050-061
N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid, HEPES10 mMLife Technologies15630-080
B2710 µl/mLGibco17504-044
N210 µl/mLGibco17502-048
Organoid seeding medium
Organoid culture medium 
Epidermal growth factor (EGF)50 ng/mLInvitrogenPMG8041
Fibroblast growth factor-10 (FGF10)100 ng/mLPeproTech100-26
Primary antibodies
Anti-Cytokeratin 19 (CK19) antibody, Rabbit1:250Abcamab53119
Sex-Determining Region Y-Box 9 (SOX9) antibody, Rabbit1:200Santa Cruzsc-20095
Pancreatic Duodenal Homeobox 1 (PDX1) antibody, Rabbit1:2000DSRBF109-D12
E-cadherin antibody, Goat1:500Santa Cruzsc-31020
Acetylated α-tubulin antibody, Mouse1:500Sigma-AldrichT6793
Secondary antibodies
488 labeled anti-rabbit, Donkey IgG1:1000InvitrogenA-21206
594 labeled anti-goat, Donkey IgG1:1000InvitrogenA-11058
568 labeled anti-mouse, Goat IgG2b1:500InvitrogenA-21144
TopFlash Wnt reporter assay
TopFlash HEK293 cell lineATCCCRL-1573
Luciferase Assay KitBiotium30003-2
0.05% Trypsin-EDTALife Technologies25300054
0.4% Trypan Blue SolutionLife Technologies15250061
Additional materials and reagents
Basement matrix, phenol free MatrigelCORNING356237
Dissociation buffer, AccutaseGibcoA1110501
Cell culture freezing medium, RecoveryLife Technologies12648010
Cell strainer (70 µm, steriled)Fisherbrand22363548
Guanidinium thiocyanate-phenol RNA extraction, TRIzolInvitrogen15596026
Specimen processing gel, HistoGelThermo Fisher ScientificHG-4000-012
Universal mycoplasma detection kitATCC30-1012K
1.5 mL microcentrifuge tubeFisherbrand05-408-129
24 well plateUSA ScientificCC7682-7524
50 mL conical centrifuge tubeFisher scientific14-432-22
Fluorescence microscopeNikonEclipse E800
Inverted microscopeBiotium30003-2
Necropsy trayFisherbrand13-814-61

References

  1. Lazaridis, K. N., LaRusso, N. F. The Cholangiopathies. Mayo Clinic Proceedings. 90 (6), 791-800 (2015).
  2. Carpino, G., et al. Stem/Progenitor Cell Niches Involved in Hepatic and Biliary Regeneration. Stem Cells International

Explore More Articles

OrganoidsExtrahepatic Bile DuctsMurineCholangiopathiesPreclinical ModelsCholangiocyteTissue RegenerationCell to cell InteractionsBile Duct IsolationDissociationBasement MatrixCell Culture

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved